Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-22-000006

Chief Commercial Officer sold 6,857 shares at $17.72 ($121,506)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-15 Sale : show line 1 in the form −6,857 $17.72 $121,506 49,729 D
Open-market sales · 6,857 sh · avg $17.72 · $121,506
Loading xslF345X03/wf-form4_166872420553318.xml…